NANCEE ALBRIGHT: Open Payments
NPI 1225395270 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 24 payments from 12 companies in 2025. Trend: 2023 $863 · 2024 $658 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $155 |
| Novartis Pharmaceuticals Corporation | 6 | $111 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Astellas Pharma US Inc | 3 | $52 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| BeOne Medicines USA, Inc. | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| TerSera Therapeutics LLC | 1 | $16 |
Products named: Zynyz, LUTATHERA, KEYTRUDA, Enhertu, Vyloy, Orserdu, JAKAFI, Fabhalta.
Industry payments across OH — which companies pay providers there.
